Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

SHE:002693 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	4,375	2,886	7,601	3,129	3,015	1,945
Market Cap Growth	-14.16%	-62.03%	142.94%	3.77%	55.05%	10.89%
Enterprise Value	4,599	3,136	7,793	3,255	3,130	2,127
Last Close Price	10.55	6.96	18.33	7.51	7.27	4.72
PE Ratio	123.56	151.56	-	-	334.55	-
Forward PE	-	18.69	18.69	18.69	18.69	18.69
PS Ratio	15.16	10.43	43.63	13.26	10.97	6.07
PB Ratio	10.42	6.86	18.47	6.04	5.19	3.43
P/TBV Ratio	13.91	9.38	22.66	7.47	6.83	4.83
P/FCF Ratio	111.43	163.27	-	-	-	-
P/OCF Ratio	50.88	47.36	-	268.82	119.56	82.56
EV/Sales Ratio	15.94	11.33	44.73	13.80	11.39	6.64
EV/EBITDA Ratio	54.48	44.81	-	205.51	235.43	451.32
EV/EBIT Ratio	143.70	180.72	-	-	-	-
EV/FCF Ratio	117.14	177.38	-	-	-	-
Debt / Equity Ratio	0.70	0.67	0.67	0.36	0.38	0.31
Debt / EBITDA Ratio	3.49	4.01	-	11.75	16.80	37.71
Debt / FCF Ratio	7.50	15.88	-	-	-	-
Net Debt / Equity Ratio	0.53	0.53	0.56	0.30	0.13	0.18
Net Debt / EBITDA Ratio	2.61	3.17	-12.63	9.73	5.82	21.36
Net Debt / FCF Ratio	5.61	12.54	-3.52	-4.10	-9.96	-12.45
Asset Turnover	0.37	0.34	0.22	0.28	0.31	0.36
Inventory Turnover	1.79	1.81	1.09	1.18	1.57	1.62
Quick Ratio	0.42	0.45	0.41	0.43	0.58	1.01
Current Ratio	0.66	0.67	0.88	0.97	0.79	1.53
Return on Equity (ROE)	5.33%	2.14%	-22.87%	-13.10%	-1.48%	-7.00%
Return on Assets (ROA)	2.54%	1.35%	-5.65%	-2.69%	-3.13%	-3.52%
Return on Invested Capital (ROIC)	4.99%	2.70%	-10.92%	-5.54%	-6.67%	-7.15%
Return on Capital Employed (ROCE)	6.20%	3.30%	-11.80%	-5.60%	-7.50%	-6.60%
Earnings Yield	0.74%	0.66%	-1.03%	-1.62%	0.30%	-1.04%
FCF Yield	0.90%	0.61%	-0.86%	-1.20%	-0.26%	-0.42%
Payout Ratio	22.20%	38.16%	-	-	123.52%	-
Buyback Yield / Dilution	7.58%	7.59%	2.53%	6.16%	-10.85%	0.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.